Overview
TargetSeq® EBV Panel is designed for EBV typing, EBV mutation detection and EBV-host genomic integration site analysis. It is suitable for EBV-related cancer research including nasopharyngeal carcinoma, lymphoma and stomach cancer.
TargetSeq® EBV Panel is designed for EBV typing, EBV mutation detection and EBV-host genomic integration site analysis. It is suitable for EBV-related cancer research including nasopharyngeal carcinoma, lymphoma and stomach cancer.
Panel Number | T2273XV1 |
Technical Platform | TargetSeq® Hybridization Capture Sequencing |
Coverage Size | 52.4 Mb |
Reference Database | NCBI/Taxonomy |
Reference Genome | 306 full-length sequence of EBV |
Coverage | EBV genome full length |
Storage | -20℃±5℃ |
Sequence Platform | Illumina / MGI |
Recommend Sequencing Read Length | PE150 |
Recommend Sequencing Data Size and Depth | 1 Gb |
Panel designed based on the full length of 304 EBV genome sequences.
Compatible with various sample types such as tissue, cells, and plasma.
Compatible with both Illumina and MGI sequencing platforms.
Virus typing, mutation site analysis, and virus-host genome fusion site analysis can be performed.